Paul Arndt | Investor Relations |
Bill Enright | Chief Executive Officer |
Elizabeth Czerepak | Chief Financial Officer and Executive Vice President, Corporate Development |
Sybil Tasker | Chief Medical Officer |
Scot Roberts | Chief Scientific Officer |
Sarah Weber | Piper Jaffray |
Good day and welcome to the Altimmune Year End 2017 Earnings Call. Today’s conference is being recorded. At this time, I would like to turn things over to Paul Arndt [ph]. Please go ahead.
Thank you, Kayla and thank you everyone for participating in today’s 2017 year end earnings conference call.